Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
AbCellera (Nasdaq: ABCL) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx ...
Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...
NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...
AI & Biotech Labs: How Data, Automation & Analytics Are Transforming Research and Delivery Eddie Hall, AIA is a Project Architect and senior associate at MBH Architects, a multi-disciplinary firm ...
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...
Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...
Woods noted that Biogen has multiple focuses across autoimmune kidney diseases and Alzheimer's, unlike many names in the ...
"First they crawled... now they seem to be evolving through information exchange." 🧟 Evolving zombies! Well Go USA has ...
Train to Busan’s director just dropped the first look at his return to zombie horror, and it looks absolutely terrifying.
Diagnostics specialist Beckman Coulter has expanded its portfolio of Alzheimer’s disease diagnostics by earning a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results